Search
Scaling
go.drugbank.com/conditions/DBCOND0094899Drugs: Salicylic acidSynonyms: Changes in skin textureN-acetyltyrosine
go.drugbank.com/drugs/DB11102ApprovedInvestigationalN-acetyltyrosine, also referred to as N-acetyl-L-tyrosine, is used in place of as a tyrosine precursor. [DB00135] is a non-essential amino acid with a polar side group. … It is typically administered as a source of nutritional support where oral nutrition is inadequate or cannot be tolerated.
Mixtures: Aminosyn II and Dextrose, Aminosyn II and DextroseCategories: Amino Acids, Peptides, and ProteinsEthinylestradiol
go.drugbank.com/drugs/DB00977ApprovedInvestigationalEthinylestradiol was first synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering.[A191107] It was developed in an effort to create an estrogen with greater oral bioavailability. … [A191107] These properties were achieved by the substitution of an ethinyl group at carbon 17 of [estradiol].[A191107] Ethinylestradiol soon replaced [mestranol] in contraceptive pills.
Mixtures: Alisma 2mg/35µg Filmtabletten, ADELLA MINI TABLETA CON RECUBRIMIENTO DE GELATINACategories: Hormones and Related Agents, dienogest and ethinylestradiolHaemorrhoids
go.drugbank.com/conditions/DBCOND0010582Drugs: Aluminum subacetate · Balsam of Peru · Benzalkonium · Benzocaine · Bismuth oxide · Bismuth subgallate +27 moreSynonyms: Hemorrhoids and perianal venous thrombosisVomiting, Postoperative
go.drugbank.com/conditions/DBCOND0089766Drugs: DiphenidolSynonyms: Postoperative Nausea and VomitingElafibranor
go.drugbank.com/drugs/DB05187ApprovedInvestigationalElafibranor is a dual peroxisome proliferator-activated receptor (PPAR) α and β/δ agonist [A263833] that works to inhibit bile acid synthesis. … [L50773] The drug was also approved by the EMA on September 23, 2024.[L51878]
Categories: Bile and Liver Therapy, Alimentary Tract and MetabolismPraziquantel
go.drugbank.com/drugs/DB01058ApprovedInvestigationalVet approved[A263201] The efficacy of praziquantel in treating parasitic flatworms infection with low cost (~US$0.20 drug cost to treat a child) makes it an integral to WHO's plan to eliminate schistosomiasis by 2030 … Specifically, it is known as a treatment of trematodes and cestodes infections such as schistosomiasis, taeniasis, and cysticercosis.
Categories: Quinoline Derivatives and Related Substances, Antiparasitic Products, Insecticides and RepellentsProducts: CISTICID ® 600MGVanzacaftor
go.drugbank.com/drugs/DB18373ApprovedInvestigational[L52275,A179677] Vanzacaftor was first approved by the US FDA in December 2024 in combination with another CFTR corrector - [tezacaftor], which binds to a different site than vanzacaftor - and [deutivacaftor … It is used alongside other CFTR correctors and CFTR potentiators to increase the quantity and function of CFTR at the cell surface in patients with cystic fibrosis.
Categories: deutivacaftor, tezacaftor and vanzacaftorBelumosudil
go.drugbank.com/drugs/DB16703ApprovedInvestigationalimmune dysregulation by shifting the balance between Th17 cells and T-regulatory cells, thereby dampening the inflammatory cascade that can occasionally be fatal. … [L34754] In July 2022, Belumosudil was approved by Health Canada under the brand name RHOLISTIQ to treat the same condition in adult and pediatric patients 12 years or older.[L42925]
Categories: Antineoplastic and Immunomodulating AgentsPelvic Inflammatory Disease (PID)
go.drugbank.com/conditions/DBCOND0058270Synonyms: Inflammatory disease of female pelvic organs AND/OR tissues, Inflammatory disease of female pelvic organs and tissues, NOS